Premium
BioXcel Therapeutics Inc (BTAI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-04 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 10,66k | 0,00 | Derivative Exercise and Retained Stock | - | 26,18k | 68,65% |
| 2026-05-04 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | -6,85k | 7,43k | Derivative Exercise and Sale | 1,09 | 26,18k | - |
| 2026-05-04 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 10,94k | 0,00 | Derivative Exercise and Retained Stock | - | 26,80k | 68,97% |
| 2026-05-04 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | -6,56k | 7,11k | Derivative Exercise and Sale | 1,08 | 26,80k | - |
| 2026-05-04 | Mr. Richard I. SteinhartSenior VP & CFO | 10,66k | 0,00 | Derivative Exercise and Retained Stock | - | 26,30k | 68,10% |
| 2026-05-04 | Mr. Richard I. SteinhartSenior VP & CFO | -6,85k | 7,43k | Derivative Exercise and Sale | 1,09 | 26,30k | - |
| 2026-05-04 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | -19,42k | 21,11k | Derivative Exercise and Sale | 1,09 | 69,72k | - |
| 2026-05-04 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 30,34k | 0,00 | Derivative Exercise and Retained Stock | - | 69,72k | 77,03% |
| 2026-05-01 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 9,00k | 0,00 | Derivative Exercise and Retained Stock | - | 15,52k | 138,04% |
| 2026-05-01 | Mr. Richard I. SteinhartSenior VP & CFO | 9,00k | 0,00 | Derivative Exercise and Retained Stock | - | 15,65k | 135,44% |
| 2026-05-01 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 9,00k | 0,00 | Derivative Exercise and Retained Stock | - | 15,86k | 131,14% |
| 2026-03-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 383,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,38k | 1,82% |
| 2026-03-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,65k | 1,03% |
| 2026-03-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,86k | 1,00% |
| 2026-03-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,52k | 1,05% |
| 2025-12-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 383,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,00k | 1,86% |
| 2025-12-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,80k | 1,01% |
| 2025-12-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,58k | 1,04% |
| 2025-12-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,45k | 1,07% |
| 2025-10-31 | Mr. David J. MackIndependent Director | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 20,32k | 9,10% |
| 2025-09-30 | Mr. David J. MackIndependent Director | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 18,62k | 10,01% |
| 2025-09-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 382,00 | 0,00 | Derivative Exercise and Retained Stock | - | 20,62k | 1,89% |
| 2025-09-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,51k | 1,06% |
| 2025-09-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,73k | 1,02% |
| 2025-09-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,38k | 1,08% |
| 2025-08-31 | Mr. David J. MackIndependent Director | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 16,93k | 11,11% |
| 2025-07-31 | Mr. David J. MackIndependent Director | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 15,24k | 12,50% |
| 2025-07-22 | Mr. Richard I. SteinhartSenior VP & CFO | 625,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,44k | 10,75% |
| 2025-07-22 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 625,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,66k | 10,36% |
| 2025-06-30 | Mr. David J. MackIndependent Director | 1,69k | 0,00 | Derivative Exercise and Retained Stock | - | 13,54k | 14,29% |
| 2025-06-14 | Mr. Richard I. SteinhartSenior VP & CFO | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,44k | 4,95% |
| 2025-06-14 | Dr. Frank D. YoccaExec. VP & Chief Scientific Officer | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,94k | 3,63% |
| 2025-06-14 | Dr. Vimal D. MehtaFounder, CEO, President, & Director | 382,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,61k | 9,03% |
| 2025-06-14 | Mr. Javier RodriguezSenior VP, Chief Legal Officer & Corporate Secretary | 68,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,66k | 4,27% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
